296 related articles for article (PubMed ID: 35886548)
1. A Cross-Sectional Study of the Marital Attitudes of Pregnant Women at Risk for Cystic Fibrosis and Psychological Impact of Prenatal Screening.
Popa ZL; Margan MM; Petre I; Bernad E; Stelea L; Chiriac VD; Craina M; Ciuca IM; Bina AM
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886548
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis carrier population screening in the primary care setting.
Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of a cystic fibrosis carrier testing clinic for couples.
Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
[TBL] [Abstract][Full Text] [Related]
4. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterisation of circulating fetal cells allows non-invasive prenatal diagnosis of cystic fibrosis.
Saker A; Benachi A; Bonnefont JP; Munnich A; Dumez Y; Lacour B; Paterlini-Brechot P
Prenat Diagn; 2006 Oct; 26(10):906-16. PubMed ID: 16832834
[TBL] [Abstract][Full Text] [Related]
6. Reproductive decision making of aunts and uncles of a child with cystic fibrosis: genetic risk perception and attitudes toward carrier identification and prenatal diagnosis.
Denayer L; Evers-Kiebooms G; De Boeck K; Van den Berghe H
Am J Med Genet; 1992 Sep; 44(1):104-11. PubMed ID: 1519639
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Carrier Frequency of CFTR Gene Mutations in Pregnancies With Echogenic Bowel in Nova Scotia and Prince Edward Island.
Miller ME; Allen VM; Brock JK
J Obstet Gynaecol Can; 2018 Jul; 40(7):896-902. PubMed ID: 29503250
[TBL] [Abstract][Full Text] [Related]
8. CFTR DeltaF508 mutation detection from dried blood samples in the first trimester of pregnancy: a possible routine prenatal screening strategy for cystic fibrosis?
Konialis CP; Hagnefelt B; Kazamia C; Karapanou S; Pangalos C
Fetal Diagn Ther; 2007; 22(1):41-4. PubMed ID: 17003555
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
[TBL] [Abstract][Full Text] [Related]
10. Guidelines for Cystic Fibrosis Carrier Screening in the Prenatal/Preconception Period.
Hopkins MK; Dugoff L; Kuller JA
Obstet Gynecol Surv; 2022 Oct; 77(10):606-610. PubMed ID: 36242530
[TBL] [Abstract][Full Text] [Related]
11. Newborn bloodspot screening for cystic fibrosis: What do antenatal and postnatal women know about cystic fibrosis?
Fitzgerald C; Linnane B; Heery E; Conneally N; George S; Fitzpatrick P
J Cyst Fibros; 2016 Jul; 15(4):436-42. PubMed ID: 26708264
[TBL] [Abstract][Full Text] [Related]
12. The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.
Hartley NE; Scotcher D; Harris H; Williamson P; Wallace A; Craufurd D; Harris R
J Med Genet; 1997 Jun; 34(6):459-64. PubMed ID: 9192264
[TBL] [Abstract][Full Text] [Related]
13. Analysis of 3208 cystic fibrosis prenatal diagnoses: impact of carrier screening guidelines on distribution of indications for CFTR mutation and IVS-8 poly(T) analyses.
Rohlfs EM; Weinblatt VJ; Treat KJ; Sugarman EA
Genet Med; 2004; 6(5):400-4. PubMed ID: 15371904
[TBL] [Abstract][Full Text] [Related]
14. Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine.
Stalker HJ; Jonasson AR; Hopfer SM; Collins MS
Pediatr Pulmonol; 2023 Dec; 58(12):3478-3486. PubMed ID: 37712603
[TBL] [Abstract][Full Text] [Related]
15. Prenatal screening for cystic fibrosis carriers: an economic evaluation.
Rowley PT; Loader S; Kaplan RM
Am J Hum Genet; 1998 Oct; 63(4):1160-74. PubMed ID: 9758600
[TBL] [Abstract][Full Text] [Related]
16. Preconception and prenatal cystic fibrosis carrier screening of African Americans reveals unanticipated frequencies for specific mutations.
Monaghan KG; Bluhm D; Phillips M; Feldman GL
Genet Med; 2004; 6(3):141-4. PubMed ID: 15354332
[TBL] [Abstract][Full Text] [Related]
17. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
[TBL] [Abstract][Full Text] [Related]
18. Highlighting the impact of cascade carrier testing in cystic fibrosis families.
Duguépéroux I; L'Hostis C; Audrézet MP; Rault G; Frachon I; Bernard R; Parent P; Blayau M; Schmitt S; Génin E; Férec C; Scotet V
J Cyst Fibros; 2016 Jul; 15(4):452-9. PubMed ID: 27013383
[TBL] [Abstract][Full Text] [Related]
19. Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.
Watson EK; Marchant J; Bush A; Williamson B
J Med Genet; 1992 Jul; 29(7):490-1. PubMed ID: 1640429
[TBL] [Abstract][Full Text] [Related]
20. The impact of a national population carrier screening program on cystic fibrosis birth rate and age at diagnosis: Implications for newborn screening.
Stafler P; Mei-Zahav M; Wilschanski M; Mussaffi H; Efrati O; Lavie M; Shoseyov D; Cohen-Cymberknoh M; Gur M; Bentur L; Livnat G; Aviram M; Alkrinawi S; Picard E; Prais D; Steuer G; Inbar O; Kerem E; Blau H
J Cyst Fibros; 2016 Jul; 15(4):460-6. PubMed ID: 26386752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
